UK Fusion Biopsy Market Size & Outlook, 2024-2030
UK fusion biopsy market, 2018-2030 (US$M)
Related Markets
UK fusion biopsy market highlights
- The UK fusion biopsy market generated a revenue of USD 27.0 million in 2024 and is expected to reach USD 45.9 million by 2030.
- The UK market is expected to grow at a CAGR of 9.2% from 2025 to 2030.
- In terms of segment, transrectal was the largest revenue generating biopsy route in 2024.
- Transperineal is the most lucrative biopsy route segment registering the fastest growth during the forecast period.
Fusion biopsy market data book summary
| Market revenue in 2024 | USD 27.0 million |
| Market revenue in 2030 | USD 45.9 million |
| Growth rate | 9.2% (CAGR from 2024 to 2030) |
| Largest segment | Transrectal |
| Fastest growing segment | Transperineal |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Transrectal, Transperineal |
| Key market players worldwide | Koninklijke Philips NV, Hitachi Ltd, Esaote, Eigen, MedCom, Koelis, Focal Healthcare, UC Care |
Other key industry trends
- In terms of revenue, UK accounted for 3.7% of the global fusion biopsy market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany fusion biopsy market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 45.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Fusion Biopsy Market Scope
Fusion Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK fusion biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fusion biopsy market will help companies and investors design strategic landscapes.
Transrectal was the largest segment with a revenue share of 84.07% in 2024. Horizon Databook has segmented the UK fusion biopsy market based on transrectal, transperineal covering the revenue growth of each sub-segment from 2018 to 2030.
Prostate cancer is most common among men in the UK, with almost 40,000 new cases being diagnosed each year. The NHS is one of the largest medical service providers for prostate cancer diagnosis in the country.
In March 2018, the NHS announced its plans to adopt a new approach, called rapid pathway, to reduce the diagnosis time for prostate cancer from weeks to a one-day procedure. In line with this initiative, the organization started installing MRI units and fusion biopsy machines in a few hospitals within the UK.
They have planned to further extend this approach to more hospitals across the country, owing to positive outcomes. Such initiatives are expected to boost the demand for fusion imaging systems in the UK, driving the market.
Reasons to subscribe to UK fusion biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK fusion biopsy market databook
-
Our clientele includes a mix of fusion biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK fusion biopsy market , including forecasts for subscribers. This country databook contains high-level insights into UK fusion biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK fusion biopsy market size, by biopsy route, 2018-2030 (US$M)
UK Fusion Biopsy Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
